Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02552004
Other study ID # 15-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 13, 2015
Est. completion date February 1, 2018

Study information

Verified date March 2019
Source IHU Strasbourg
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intraoperative histological examination is a fundamental tool in surgery. Probe-based Confocal Laser Endomicroscopy (pCLE) is a new imaging technique which enables real-time, microscope-resolution imaging, currently used in endoscopy. This pilot study aims to evaluate pCLE in surgical setting. The objective is the depiction of histological rendering of normal and pathological tissues through pCLE. Feasibility of real-time diagnosis will also be assessed. All surgical conditions usually necessitating frozen section will be investigated. A total of 30 patients, with various pathology of the thyroid / parathyroid, stomach, esophagus, pancreas, adrenal, colon / small intestine, liver will be included. Diagnostic criteria will be defined by a surgeon - pathologist team and further validated by retrospective analysis of the video sequences in comparison to conventional histology slides. The data will be used to create an image bank of reference optical biopsy images. The study will allow to point out the surgical conditions in which pCLE is the most effective and reliable and could eventually replace the frozen section technique.


Description:

Intraoperative histological examination is a fundamental tool for cancer surgery (extent of surgery, resection margins, sentinel lymph node) and necessary in other circumstances like redo surgery or endocrine surgery. Using conventional frozen section technique results in the prolongation of operating time of about 40 minutes.

Probe-based Confocal Laser Endomicroscopy (pCLE) is a new imaging technique which enables real-time, microscope-resolution imaging. Specifically, after intravenous injection of a fluorescent contrast agent - in this study fluorescein will be used, the pCLE system provides video sequences of the tissue, using a confocal microscope integrated in a miniprobe and a low power laser as the illumination source (Cellvizio®, Mauna Kea Technologies, Paris, France).

The pCLE is currently used in endoscopy, mainly for the follow-up of Barrett's esophagus, colorectal polyps and strictures of the bile and pancreatic ducts, but also in urology. The pCLE has never been tested in open or video-assisted surgery settings. Sterilizable probes exist and are certified for use via an endoscope in France (UHD CystoFlexTM, AQ-FLEX 19TM Mauna Kea Technologies, Paris, France). A probe (CelioFlex UHDTM) is currently being developed for use in laparoscopic surgery setting.

This pilot study aims to evaluate pCLE in surgical setting. Each anatomical structure corresponds to a specific tissue architecture, which is today known through standard histological examination. Conventional histology implies alteration of the tissue architecture, with ablation of blood supply, sampling and technical treatment of the samples (fixation, cutting, staining). The pCLE enables to bypass this process and allows obtaining images of the microscopic structure in vivo, without cell damage and without interruption of the blood and lymphatic circulation. The obtained video sequences reflect the microscopic architecture, in a form which is to date, neither mapped nor exploited for deep organs. The potential of this technique was demonstrated in intraabdominal organs only in the animal model, with very encouraging results as the sensitivity and specificity of pCLE were superior to standard histological examination.

The primary objective is the depiction of histological rendering of normal and pathological tissues through pCLE. Feasibility of real-time diagnosis will also be assessed. All surgical conditions usually necessitating frozen section will be investigated. A total of 30 patients, with various pathology of the thyroid / parathyroid, stomach, esophagus, pancreas, adrenal, colon / small intestine, liver will be included.

The installation and surgical opening will be performed according to standard protocols. A contrast agent, fluorescein, will be injected intravenously to allow tissue visualization with the pCLE. During the surgery, the surgeon will perform the pCLE examination, to obtain and record video sequences of in situ structures. Frozen sections will be obtained on the same samples and will further guide the surgical decision-making.

Diagnostic criteria will be defined by a surgeon - pathologist team and further validated by retrospective analysis of the sequences in comparison to conventional histology slides. The data will be used to create an image bank of reference optical biopsy images.

The study will allow to point out the surgical conditions in which pCLE is the most effective and reliable and could eventually replace the frozen section technique.

A second study, in comparative prospective settings, could further be focused only on the promising conditions in order to evaluate diagnosis accuracy on a statistical basis.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date February 1, 2018
Est. primary completion date December 14, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient, male or female, over 18 years old

- Patient candidate to digestive or endocrine surgery in whom the surgeon deems necessary intraoperative frozen section

- Patient able to understand the study and to provide informed consent

- Patient affiliated to the French social security system

Exclusion Criteria:

- Patient unable to provide informed consent

- Patient with known or suspected allergy to fluorescein

- Patient who had a previous life-threatening reaction during an angiography

- Patient with a history of multiple and severe allergic reactions to medications

- Patient taking a beta-blocker treatment

- Patient with comorbidity considered by the investigator, as incompatible with the procedures of the study

- Patient pregnant or breastfeeding

- Patient in exclusion period (determined by a previous study or in progress)

- Patient having forfeited their freedom of an administrative or legal obligation

- Patient under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Device:
pCLE
Histological examination by pCLE technique preceding the frozen section
Drug:
IV fluorescein administration
IV Fluorescein (fluorescent contrast agent) administration

Locations

Country Name City State
France Service de chirurgie digestive et endocrinienne - Nouvel Hôpital Civil Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
IHU Strasbourg

Country where clinical trial is conducted

France, 

References & Publications (4)

Ignat M, Aprahamian M, Lindner V, Altmeyer A, Perretta S, Dallemagne B, Mutter D, Marescaux J. Feasibility and reliability of pancreatic cancer staging using fiberoptic confocal fluorescence microscopy in rats. Gastroenterology. 2009 Nov;137(5):1584-92.e1. doi: 10.1053/j.gastro.2009.07.045. Epub 2009 Jul 24. — View Citation

Ignat M, Lindner V, Vix M, Marescaux J, Mutter D. Intraoperative Probe-Based Confocal Endomicroscopy to Histologically Differentiate Thyroid From Parathyroid Tissue Before Resection. Surg Innov. 2019 Apr;26(2):141-148. doi: 10.1177/1553350618814078. Epub — View Citation

Kwan AS, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):33-8. — View Citation

Wallace MB, Fockens P. Probe-based confocal laser endomicroscopy. Gastroenterology. 2009 May;136(5):1509-13. doi: 10.1053/j.gastro.2009.03.034. Epub 2009 Mar 28. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnosis accuracy of intraoperative imaging with pCLE technique The diagnosis proposed by the surgeon / investigator in intraoperative setting on the basis of video sequences of pCLE will be compared to frozen section. During surgery
Secondary Diagnosis accuracy of pCLE imaging, retrospectively using the newly described diagnosis criteria The diagnosis proposed by the surgeon / investigator after retrospective review of the intraoperative video sequences of pCLE based on the newly described diagnosis criteria will be compared to frozen section and conventional histology. One year
Secondary pCLE video sequences interpretation learning curve Comparison of the surgeon's ability to obtain intraoperative diagnosis relative to that of the pathologist in the same circumstances. One year
Secondary Time needed for pCLE imaging procedure Evaluation of the time required for the practice of pCLE and comparison to the time required for frozen section. During surgery
Secondary Specific morbidity and mortality rate Morbidity rate / mortality specific to the pCLE imaging procedure. One month after surgery
See also
  Status Clinical Trial Phase
Completed NCT03964324 - NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring N/A
Recruiting NCT03963648 - NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP N/A
Not yet recruiting NCT04997343 - Neurophysiological Assessment in Patients With Multiple Sclerosis N/A
Completed NCT01695876 - A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects Phase 1
Not yet recruiting NCT05546788 - Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis Phase 1
Recruiting NCT03651518 - Personalized Therapies in Inflammatory Complex Disease Phase 2
Not yet recruiting NCT05544448 - In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases N/A
Completed NCT04368494 - Exercise Therapy in Patients With Axial Spondyloarthritis N/A
Completed NCT03878134 - Translational Development of Photon-counting CT Imaging N/A
Recruiting NCT06059989 - inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease Phase 3
Completed NCT02959138 - Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Phase 1
Active, not recruiting NCT04565821 - Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe N/A
Recruiting NCT05509075 - Nutraceuticals and Functional Foods
Active, not recruiting NCT05944822 - Pro-inflammatory Cytokines in Case of Essure®
Completed NCT05115370 - Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
Active, not recruiting NCT03604406 - The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept Phase 2
Completed NCT05022017 - Description of Statics by EOS Imaging and Evaluation of the Efficacy of Intradiscal Corticosteroid Infiltration
Recruiting NCT05364294 - Molecular Diagnosis of Systemic Autoinflammatory Diseases
Recruiting NCT05860400 - Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Completed NCT02084147 - PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases N/A